These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 6071173)
1. Tests of blood coagulation and hemostasis. 3. The partial thromboplastin time. Didisheim P JAMA; 1967 Jan; 199(3):201. PubMed ID: 6071173 [No Abstract] [Full Text] [Related]
2. [Interpretation of screening tests of hemostasis]. Wuillemin WA; Heizmann M Praxis (Bern 1994); 2003 Jan; 92(3):57-64. PubMed ID: 12577721 [TBL] [Abstract][Full Text] [Related]
3. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time. Angelos MG; Hamilton GC Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249 [TBL] [Abstract][Full Text] [Related]
4. An evaluation of the partial thromboplastin time in the detection of blood coagulation disorders. Whetham J Can J Med Technol; 1966 Jun; 28(3):81-96. PubMed ID: 5937814 [No Abstract] [Full Text] [Related]
5. The kaolin partial thromboplastin time as a screening test for coagulation disorders. Lurie A; Smith S S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371 [No Abstract] [Full Text] [Related]
7. [Partial thromboplastin time as a screening test in hemorrhagic diseases]. Vargas V; Croxato M; Ossandon A Rev Med Chil; 1970 Oct; 98(10):679-81. PubMed ID: 5504871 [No Abstract] [Full Text] [Related]
8. [Diagnostic clarification of coagulopathies]. Beck EA Schweiz Med Wochenschr; 1971 Nov; 101(46):1653-7. PubMed ID: 5140631 [No Abstract] [Full Text] [Related]
9. The use of the dilutional partial thromboplastin time in the detection of potential hypercoagulable states. Moquin RB; Ryan RM Med Ann Dist Columbia; 1966 Jun; 35(6):305-9. PubMed ID: 5219900 [No Abstract] [Full Text] [Related]
10. [Partial thromboplastin time activated with kaolin (PTTTK), a sensitive test of total plasmatic coagulability]. Poppa C; Enache F; Cernat M Stud Cercet Med Interna; 1972; 13(5):489-93. PubMed ID: 4645066 [No Abstract] [Full Text] [Related]
11. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus]. Arshinov AV; Lapin VA; Raĭt IuA Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229 [TBL] [Abstract][Full Text] [Related]
13. Relative value of screening tests of hemostasis prior to dental treatment. Redding SW; Olive JA Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):34-6. PubMed ID: 3856205 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of a capillary micro partial thromboplastin test in hemophiliac disorders. Mochir-Fatemi F; Leikin S Tech Bull Regist Med Technol; 1966 Dec; 36(12):297-301. PubMed ID: 5981168 [No Abstract] [Full Text] [Related]
15. The partial thromboplastin time test: distinction between inhibitor and clotting-factor deficiency. Knights SF; Wadey CA Med Lab Technol; 1973 Jan; 30(1):43-7. PubMed ID: 4718028 [No Abstract] [Full Text] [Related]
16. [The partial thromboplastin test in the preoperative "screening" of hemorrhagic patients]. Bracali G; Niccoli Vallesi R; Rubertelli M Ann Laringol Otol Rinol Faringol; 1967; 66(3):333-7. PubMed ID: 5632636 [No Abstract] [Full Text] [Related]
17. Partial thromboplastin time as a screening test. Robbins JA; Rose SD Ann Intern Med; 1979 May; 90(5):796-7. PubMed ID: 434687 [No Abstract] [Full Text] [Related]
18. [Cephalin time (ceph. t.) or partial thromboplastin time (P.T.T.)]. Enache F; Poppa C; Andronescu S; Cernat M Med Interna (Bucur); 1968 Dec; 20(12):1461-7. PubMed ID: 5731998 [No Abstract] [Full Text] [Related]